Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis
- 1 April 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57 (4) , 1493-1501
- https://doi.org/10.1046/j.1523-1755.2000.00994.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Molecular basis of renal disease. Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease beyond haemodynamicsNephrology Dialysis Transplantation, 1998
- Interactions of Transforming Growth Factor-β and Angiotensin II in Renal FibrosisHypertension, 1998
- Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.Journal of Clinical Investigation, 1997
- Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II DiabetesDiabetes, 1997
- Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cellsKidney International, 1997
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- The paradox of the renin-angiotensin system in chronic renal diseaseKidney International, 1994
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney diseaseNature, 1992
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990